• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 26 May 2026

SBIO: Q1 Financials In Line with Expectations


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 5 pages


 

• SBIO reported Q1 financials that were in line with our expectations, with revenue coming in at $7.2M compared to our estimate of $7.1M. Adjusted EBITDA was ($3.4M) for Q1 versus our estimate of ($3.5M). • We remind readers that Q1 is seasonally the worst quarter of the year for Sabio, and we should see much stronger results sequentially through 2026, evidenced by management’s outlook. • SBIO guided that 2026 will be a record year for revenue, given the political cycle and that it has received $5M in political spending commitments. Yesterday, after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTCQB) reported its Q1 financial results were in line with our estimates, with Q1 being its seasonally weakest quarter. We believe that the declining revenue is now in the rear-view for SBIO and it will resume growth in Q2. We are maintaining our BUY rating and target price of C$0.50/share on SBIO. Key Highlights • Q1 revenue came in at $7.2M (-21% YoY, but +6% YoY ex-political spending) compared to our $7.1M estimate. Q1 was comprised of $5.8M in ad-supported streaming revenue (-15% YoY, +18% YoY ex-political), $1.2M in mobile display revenue (-40% YoY), and $0.1M in other revenue. • International and programmatic channels (the new focus) represented 62% of the revenue mix, with each channel up 13x YoY. Additionally, 77% of its programmatic customers renewed from Q4 into Q1, despite Q1 being seasonally weaker. • SBIO also secured over $5M in political and advocacy commitments for H2. • New customer logos increased 31% YoY, with 56% of returning logos expanding their spending. Re-occurring revenue was 85% of revenue in Q1.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

SBIO: Q1 Financials In Line with Expectations


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Published: 26 May 2026
  • Author: Nicholas Cortellucci, CFA
  • Pages: 5
  • Atrium Research


• SBIO reported Q1 financials that were in line with our expectations, with revenue coming in at $7.2M compared to our estimate of $7.1M. Adjusted EBITDA was ($3.4M) for Q1 versus our estimate of ($3.5M). • We remind readers that Q1 is seasonally the worst quarter of the year for Sabio, and we should see much stronger results sequentially through 2026, evidenced by management’s outlook. • SBIO guided that 2026 will be a record year for revenue, given the political cycle and that it has received $5M in political spending commitments. Yesterday, after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTCQB) reported its Q1 financial results were in line with our estimates, with Q1 being its seasonally weakest quarter. We believe that the declining revenue is now in the rear-view for SBIO and it will resume growth in Q2. We are maintaining our BUY rating and target price of C$0.50/share on SBIO. Key Highlights • Q1 revenue came in at $7.2M (-21% YoY, but +6% YoY ex-political spending) compared to our $7.1M estimate. Q1 was comprised of $5.8M in ad-supported streaming revenue (-15% YoY, +18% YoY ex-political), $1.2M in mobile display revenue (-40% YoY), and $0.1M in other revenue. • International and programmatic channels (the new focus) represented 62% of the revenue mix, with each channel up 13x YoY. Additionally, 77% of its programmatic customers renewed from Q4 into Q1, despite Q1 being seasonally weaker. • SBIO also secured over $5M in political and advocacy commitments for H2. • New customer logos increased 31% YoY, with 56% of returning logos expanding their spending. Re-occurring revenue was 85% of revenue in Q1.

More Content

More Content

SBIO: Challenging Q4 Given Backdrop; Expecting Improvements

Companies: Sabio Holdings, Inc.

Atrium Research

SBIO: A Rising Ad-Tech Player in the Growing Streaming TV Market

Companies: Sabio Holdings, Inc.

Atrium Research

Q1/26 Recap: All Our Research in One Place!

Companies: NIM DWS SPA CUU NCI LIO REG OGO SCZ DRX AUAU ARG OMG BQE CCM LOVE GEC CUU DWS DNG EDG GTCH KRI KRI MOO NCI NIM OGO CTEK REG RIO ROMJ ESAU SPA SBIO LVG NKG TGOL ECOR AGC FRG YAY NAMM SCZ CAPT SCM LIO MSA APM MTT FISH FCLI

Atrium Research

SBIO: Preliminary Q4 Financials; Best Quarter in Company History

Companies: Sabio Holdings, Inc.

Atrium Research

Q4/25 Recap: All Our Research in One Place!

Companies: NIM DWS SPA CUU LIO REG SCZ DRX AUAU ARG OMG BQE GEC CUU DWS DNG EDG GTCH KRI KRI MOO NIM REG RIO ROMJ SPA SBIO LVG NKG EPG FRG NAMM SCZ CAPT LIO MSA APM MTT FISH FCLI

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • RBC Capital Markets
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Investor Summit
      • The Life Sciences Division
      • ThinkFront
      • Ticker TV
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Venn Brown
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In